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Figure 2. After one month of treatment: there is a noticeable improvement in the
facial lesions.
Figure 1. Erythematous papules on the face in a patient with histoplasmosis.
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hospital with disseminated cutaneous lesions that had started one
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doi:10.1016/j.ijid.2009.04.010(Figure 1) and lesions on the arms, legs, and trunk that formed
plaques and crusts. She also complained of fever and weight loss
that appeared along with the cutaneous lesions. A cutaneous
biopsy was performed and the lesions were cultured. The patient
consented to an HIV serology test, which was positive. Culture of
the lesions showed Histoplasma capsulatum and she started
treatment induction with amphotericin B and deoxycholate,ses. Published by Elsevier Ltd. All rights reserved.
V.S. Cunha et al. / International Journal of Infectious Diseases 14 (2010) e271–e272e272followed by consolidation with itraconazole. She was also started
on tenofovir, lamivudine, and efavirenz. Despite poor adherence to
therapy at home, there was great improvement of the cutaneous
lesions (Figure 2).
H. capsulatum is acquired by inhalation of mycelia and
microconidia fragments of the fungus. The fungus lives in the
soil, next to rivers, and next to birds and bats, which carry it in the
gastrointestinal tract. The disease is often self-limited or localized
in the general population, but may be disseminated and fatal in
patients with pre-existing conditions, especially those related to
immunosuppression.1 In HIV-positive patients, it is usually
described with CD4 lymphocyte counts lower than 150 cells/
mm3 (as in our case, which was 124 cells/mm3). It is important to
note that the cutaneous lesions can vary in shape, consistency, and
number in these individuals.2
Other diseases can produce cutaneous lesions in HIV patients in
this clinical setting and should be included in the differential
diagnosis. Drug eruptions, HIV-associated prurigo, scabies, psor-
iasis, and other bacterial, viral, and fungal diseases are some of the
disorders that can mimic cutaneous histoplasmosis. Therefore, the
identiﬁcation and isolation of the fungus in tissues is essential for
the correct diagnosis.3
Different studies in different hospitals have shown that H.
capsulatum strains from South America have greater dermotrop-
ism, with more mucocutaneous changes, compared with those
from North America and Europe,4–8 most probably related to
genetic differences between the strains.9Conﬂict of interest
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